EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic Syndrome Disrupts the Association Between Serum Malondialdehyde and Lipoprotein Subclasses

Marija Pinterić Mavar, Iva Klobučar, Margarete Lechleitner, Gerd Kager, Hansjörg Habisch, Lidija Hofmann, Lucija Klobučar, Gudrun Pregartner, Andrea Berghold, Tobias Madl, Saša Frank, Vesna Degoricija

Antioxidants · 07.11.2026 · 15 (11) · 1443

DOI: 10.3390/antiox15111443 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 07.11.2026. Verfasst von Marija Pinterić Mavar und 11 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malondialdehyde (MDA) is a widely used biomarker of lipid peroxidation, yet its relationships with lipoprotein subclasses remain poorly explored, particularly in metabolic syndrome (MS). We investigated associations of free MDA measured by the TBARS assay (MDA-TBARS) and total MDA quantified by high-performance liquid chromatography (MDA-HPLC) with NMR spectroscopy-measured lipoprotein subclasses in 65 healthy volunteers (HV) and 65 patients with MS. MDA-HPLC concentrations were higher than MDA-TBARS, and the two measures were strongly correlated. Free MDA levels were significantly elevated in MS, whereas total MDA did not differ between groups. In HV, MDA-TBARS showed positive relationships with VLDL and IDL, as well as triglyceride enrichment of LDL, IDL, and HDL, and a negative relationship with levels and cholesterol content of small, dense HDL, as well as cholesterol and phospholipid content of LDL subclasses. MDA-HPLC only showed a positive association with VLDL levels in HV. In contrast, no significant associations between MDA and lipoproteins were observed in MS. Multivariable analyses confirmed that lipoprotein profiles were able to discriminate between low and high MDA levels in HV, but not in patients with MS. In conclusion, interactions between oxidative stress and lipoproteins are strongly context dependent, being preserved in health but disrupted in MS, with free MDA emerging as a more informative marker of lipoprotein-associated lipid peroxidation.

Zitieren

APA

Mavar, M. P., Klobučar, I., Lechleitner, M., Kager, G., Habisch, H., Hofmann, L., Klobučar, L., Pregartner, G., Berghold, A., Madl, T., Frank, S., & Degoricija, V. (2026). Metabolic Syndrome Disrupts the Association Between Serum Malondialdehyde and Lipoprotein Subclasses. Antioxidants, 15(11), 1443. https://doi.org/10.3390/antiox15111443

Vancouver

Mavar MP, Klobučar I, Lechleitner M, Kager G, Habisch H, Hofmann L, et al. Metabolic Syndrome Disrupts the Association Between Serum Malondialdehyde and Lipoprotein Subclasses. Antioxidants. 2026;15(11):1443. doi:10.3390/antiox15111443

BibTeX
@article{Mavar2026,
  author = {Mavar, Marija Pinterić and Klobučar, Iva and Lechleitner, Margarete and Kager, Gerd and Habisch, Hansjörg and Hofmann, Lidija and Klobučar, Lucija and Pregartner, Gudrun and Berghold, Andrea and Madl, Tobias and Frank, Saša and Degoricija, Vesna},
  title = {Metabolic Syndrome Disrupts the Association Between Serum Malondialdehyde and Lipoprotein Subclasses},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {1443},
  doi = {10.3390/antiox15111443}
}
Kostenlos starten →